Skip to main content
Caplight Logo









Arsenale Bioyards

Arsenale Bioyards

Private
MilanFrontier & Industrial Techhttps://arsenale.bio/

Last Round

Seed

Feb 25, 2025

Total Funding Raised

$10M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Arsenale Bioyards is a biotechnology company that provides an AI-driven, end-to-end biomanufacturing platform for the scalable production of bio-based alternatives to petrochemical and animal-derived products.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Clean Manufacturing, Sustainable Materials, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

biomanufacturingprecision fermentationbiomanufacturing-as-a-servicebiofoundrybiotech scale-upsynthetic biologybioprocess engineeringindustrial biotechnologybioreactorstrain optimizationsustainable materialscontract manufacturingbio-based alternativesai-driven bioprocessinglab-to-industrial scale

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arsenale Bioyards Comparables

Compare Arsenale Bioyards with similar companies based on industry and business-model similarity.

Arsenale Bioyards comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Boston Bioprocess
78%
Planetary
78%
Pow.Bio
77%

Arsenale Bioyards Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 25, 2025

Key People

Founding team and executive leadership

Massimo Portincaso

CEO & Co-Founder

Founding Team

Arsenale Bioyards Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 6, 2026

    Open roles increased from 0 to 11, representing 31% of headcount.

  • Feb 25, 2025

    $10M round led by byFounders and Planet A Ventures.

Arsenale Bioyards Filings

Explore SEC and related filing metadata, where available.

Arsenale Bioyards filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Arsenale Bioyards's valuation, stock price, and market status.

Is Arsenale Bioyards a public or private company?

Arsenale Bioyards is a private company.

What is the current stock price of Arsenale Bioyards?

Arsenale Bioyards is a private company with no public stock price. No recent secondary market data is available.

How much is Arsenale Bioyards worth (valuation)?

Valuation information for Arsenale Bioyards is not publicly available.

Can I buy Arsenale Bioyards stock?

Arsenale Bioyards shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Arsenale Bioyards's last funding round?

Arsenale Bioyards's most recent funding round was Seed on February 25, 2025.

Who are the main investors in Arsenale Bioyards?

Key investors in Arsenale Bioyards include Planet A Ventures, byFounders.

Will Arsenale Bioyards IPO soon?

No public IPO plans have been announced for Arsenale Bioyards.

How can I track Arsenale Bioyards secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Arsenale Bioyards's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMilan
Employee Range34
Year Founded2023
Last FundingFeb 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?